Research & Innovation Centers

Unlocking the Power of Research & Innovation

Ventas is the leading owner of university-based Research & Innovation (R&I) real estate. With demand in the $140+ billion life science real estate market expected to rise to more than $170 billion within five years,¹ the R&I portfolio is the Company’s top capital allocation priority, with more than $2 billion invested in R&I since 2016.

Together with our exclusive development partner Wexford Science & Technology, we are actively expanding our R&I portfolio through the evolution of vibrant, amenity-rich, mixed-use Knowledge Communities that are built on a foundation of research, discovery and entrepreneurial activity. With 34 operating properties in 13 hub markets and a $1.5 billion pipeline of near-term developments, Ventas is well-positioned for long-term growth supported by the economic drivers of reliable tenants, long-term lease commitments and sustained occupancy.

The Knowledge Community ecosystem has a unique ability to attract a wide variety of valuable tenants to the urban “live, work, play, learn” environments that leverage talent, services and amenities in a single location. More than 95% of our properties are anchored by leading research universities, with other tenants including start-ups and innovation incubators such as Cambridge Innovation Centers and BioLabs; established biotech / biopharma companies including Alexion Pharmaceuticals, Spark Therapeutics, Paragon Pharmaceuticals and Amicus Therapeutics; and established corporate and technology companies like Microsoft, Boeing and Aon.